EGFR and cancer: Different antibodies, like Trastuzumab, Pertuzumab (anti-HER2), Matuzumab (anti-EGFR) can all be respectively fused with MICA and used together as a cocktail, so that multiple antigens in cancer can be targeted at the same time.